Connection

Barbara Wiggins to Dyslipidemias

Back to Details
This is a "connection" page, showing publications Barbara Wiggins has written about Dyslipidemias.
Barbara Wiggins
Connection Strength
1.794
Dyslipidemias
  1. Human Angiopoietin-like Protein 3/ANGPTL3 Antibodies: Adding to the Armamentarium in the Management of Dyslipidemia. J Cardiovasc Pharmacol. 2021 11 01; 78(5):e631-e640.
    View in: PubMed
    Score: 0.700
  2. Key Articles and Guidelines in the Management of Dyslipidemia: 2019 Update. J Pharm Pract. 2020 Dec; 33(6):882-894.
    View in: PubMed
    Score: 0.600
  3. Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2016 11 22; 134(21):e468-e495.
    View in: PubMed
    Score: 0.494
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.